Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May 31:16:1387-1406.
doi: 10.2147/CCID.S385861. eCollection 2023.

Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs

Affiliations
Review

Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs

Michael Kaiser et al. Clin Cosmet Investig Dermatol. .

Abstract

Androgenetic alopecia (AGA) is the most common cause of hair loss in men and women. Traditionally, topical minoxidil and oral finasteride have been the standard of care yielding mixed results. New treatments such as Low-Level Laser Therapy (LLLT), microneedling, platelet-rich plasma (PRP), and others have been extensively studied in the literature, and the purpose of this review is to provide a comprehensive discussion of the latest treatment methods and their efficacy in treating AGA. Novel therapies such as oral minoxidil, topical finasteride, topical spironolactone, botulinum toxin, and stem cell therapy offer interesting alternatives to standard of care therapies for patients. In this review, we present data from recent studies on the clinical efficacy of these treatments. Furthermore, as new treatments have emerged, clinicians have tested combination therapies to assess whether there may be a synergistic relationship between multiple modalities. While there has been a great increase in the treatments available for AGA, the quality of evidence varies greatly and there is still a great need for randomized double blinded clinical trials to adequately assess the clinical efficacy of some treatments. While PRP and LLLT have demonstrated encouraging results, standardized treatment protocols are needed to adequately inform clinicians on how to use such therapies. Given the abundance of new therapeutic options, clinicians and patients must weigh the benefits and risks of each treatment option for AGA.

Keywords: androgenetic alopecia; finasteride; microneedling; minoxidil; platelet rich plasma.

PubMed Disclaimer

Conflict of interest statement

Dr Naiem T Issa reports a patent WO2021178871A1 issued to University of Miami. The authors report no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
Efficacy of Low-level laser therapy for the treatment of androgenetic alopecia. Reproduced from Suchonwanit P, Chalermroj N, Khunkhet S. Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women: a 24-week, randomized, double-blind, sham device-controlled trial. Lasers Med Sci. 2019;34(6):1107–1114. Creative Commons Attribution 4.0 International License. (https://creativecommons.org/licenses/by/4.0/).
Figure 2
Figure 2
Before and after of a patient with AGA treated with PRP and microneedling. Reproduced from Aggarwal K, Gupta S, Jangra RS, Mahendra A, Yadav A, Sharma A. Dermoscopic assessment of microneedling alone versus microneedling with platelet-rich plasma in cases of male pattern alopecia: a split-head comparative study. Int J Trichol. 2020;12(4): 156, under the Creative Commons Attribution-Non Commercial-ShareAlike 4.0 License.

References

    1. Lolli F, Pallotti F, Rossi A, et al. Androgenetic alopecia: a review. Endocrine. 2017;57(1):9–17. doi:10.1007/s12020-017-1280-y - DOI - PubMed
    1. Price VH. Androgenetic alopecia in women. J Investig Dermatol Symp Proc. 2003;8(1):24–27. doi:10.1046/j.1523-1747.2003.12168.x - DOI - PubMed
    1. Trüeb RM. Molecular mechanisms of androgenetic alopecia. Exp Gerontol. 2002;37(8–9):981–990. doi:10.1016/S0531-5565(02)00093-1 - DOI - PubMed
    1. Kaliyadan F, Nambiar A, Vijayaraghavan S. Androgenetic alopecia: an update. Indian J Dermatol Venereol Leprol. 2013;79(5):613. doi:10.4103/0378-6323.116730 - DOI - PubMed
    1. Ho CH, Sood T, Zito PM. Androgenetic alopecia. In: StatPearls. StatPearls Publishing; 2021. - PubMed